关注
Brian M. Barth
Brian M. Barth
在 alaska.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin
WL Holland, RA Miller, ZV Wang, K Sun, BM Barth, HH Bui, KE Davis, ...
Nature medicine 17 (1), 55-63, 2011
10192011
Near-Infrared Emitting Fluorophore-Doped Calcium Phosphate Nanoparticles for In Vivo Imaging of Human Breast Cancer
EI Altınogˇlu, TJ Russin, JM Kaiser, BM Barth, PC Eklund, M Kester, ...
Acs Nano 2 (10), 2075-2084, 2008
4852008
Genome mining of biosynthetic and chemotherapeutic gene clusters in Streptomyces bacteria
KC Belknap, CJ Park, BM Barth, CP Andam
Scientific Reports 10 (1), 2003, 2020
1802020
Targeted Indocyanine-Green-Loaded Calcium Phosphosilicate Nanoparticles for In Vivo Photodynamic Therapy of Leukemia
BM Barth, E I. Altinoğlu, SS Shanmugavelandy, JM Kaiser, ...
Acs Nano 5 (7), 5325-5337, 2011
1752011
Bioconjugation of Calcium Phosphosilicate Composite Nanoparticles for Selective Targeting of Human Breast and Pancreatic Cancers In Vivo
BM Barth, R Sharma, EI Altınogˇlu, TT Morgan, SS Shanmugavelandy, ...
ACS nano 4 (3), 1279-1287, 2010
1582010
Nanoliposomal ceramide prevents in vivo growth of hepatocellular carcinoma
HRS Tagaram, NA DiVittore, BM Barth, JM Kaiser, D Avella, ET Kimchi, ...
Gut 60 (5), 695-701, 2011
1002011
Proinflammatory cytokines provoke oxidative damage to actin in neuronal cells mediated by Rac1 and NADPH oxidase
BM Barth, S Stewart-Smeets, TB Kuhn
Molecular and Cellular Neuroscience 41 (2), 274-285, 2009
842009
Acid ceramidase is upregulated in AML and represents a novel therapeutic target
SF Tan, X Liu, TE Fox, BM Barth, A Sharma, SD Turner, A Awwad, ...
Oncotarget 7 (50), 83208, 2016
832016
Combinatorial therapies improve the therapeutic efficacy of nanoliposomal ceramide for pancreatic cancer
Y Jiang, NA DiVittore, JM Kaiser, SS Shanmugavelandy, JL Fritz, ...
Cancer biology & therapy 12 (7), 574-585, 2011
742011
Neutral sphingomyelinase activation precedes NADPH oxidase‐dependent damage in neurons exposed to the proinflammatory cytokine tumor necrosis factor‐α
BM Barth, SJ Gustafson, TB Kuhn
Journal of neuroscience research 90 (1), 229-242, 2012
682012
Metabolism of short-chain ceramide by human cancer cells—implications for therapeutic approaches
JV Chapman, V Gouazé-Andersson, MC Messner, M Flowers, R Karimi, ...
Biochemical pharmacology 80 (3), 308-315, 2010
622010
Exogenous ceramide-1-phosphate reduces lipopolysaccharide (LPS)-mediated cytokine expression
JL Hankins, TE Fox, BM Barth, KA Unrath, M Kester
Journal of Biological Chemistry 286 (52), 44357-44366, 2011
602011
Ceramide 1-phosphate mediates endothelial cell invasion via the annexin a2-p11 heterotetrameric protein complex
JL Hankins, KE Ward, SS Linton, BM Barth, RV Stahelin, TE Fox, M Kester
Journal of Biological Chemistry 288 (27), 19726-19738, 2013
552013
Maritoclax induces apoptosis in acute myeloid leukemia cells with elevated Mcl-1 expression
K Doi, Q Liu, K Gowda, BM Barth, D Claxton, S Amin, TP Loughran Jr, ...
Cancer biology & therapy 15 (8), 1077-1086, 2014
462014
Cholecystokinin mediates progression and metastasis of pancreatic cancer associated with dietary fat
GL Matters, TK Cooper, CO McGovern, EL Gilius, J Liao, BM Barth, ...
Digestive diseases and sciences 59, 1180-1191, 2014
452014
Inhibition of NADPH oxidase by glucosylceramide confers chemoresistance
BM Barth, SJ Gustafson, MM Young, TE Fox, SS Shanmugavelandy, ...
Cancer biology & therapy 10 (11), 1126-1136, 2010
432010
PhotoImmunoNanoTherapy reveals an anticancer role for sphingosine kinase 2 and dihydrosphingosine-1-phosphate
BM Barth, SS Shanmugavelandy, JM Kaiser, C McGovern, EI Altınoğlu, ...
ACS nano 7 (3), 2132-2144, 2013
392013
Gaucher's disease and cancer: a sphingolipid perspective
BM Barth, SS Shanmugavelandy, DM Tacelosky, M Kester, SAF Morad, ...
Critical Reviews™ in Oncogenesis 18 (3), 2013
392013
Ceramide kinase regulates TNFα-stimulated NADPH oxidase activity and eicosanoid biosynthesis in neuroblastoma cells
BM Barth, SJ Gustafson, JL Hankins, JM Kaiser, JK Haakenson, M Kester, ...
Cellular signalling 24 (6), 1126-1133, 2012
392012
Sphingolipid metabolism determines the therapeutic efficacy of nanoliposomal ceramide in acute myeloid leukemia
BM Barth, W Wang, PT Toran, TE Fox, C Annageldiyev, RM Ondrasik, ...
Blood advances 3 (17), 2598-2603, 2019
352019
系统目前无法执行此操作,请稍后再试。
文章 1–20